Qualcomm, Novartis Team Up For Remotely Monitored COPD Inhaler
This article was originally published in The Gray Sheet
Executive Summary
In its continued bid to expand the reach of its 2net connected health system, Qualcomm is working with Novartis to develop a new inhaler for patients with chronic obstructive pulmonary disease that can be used to remotely monitor treatment effectiveness.
You may also be interested in...
Voices From mHealth 2015: Qualcomm Exec Urges Device Firms To Focus On Usability
As Qualcomm Life continues to build partnerships that allow medical devices to connect through their 2net platform and share patient information, James Mault, the company's chief medical officer, emphasizes that companies should redesign products so they are more user-friendly for patients as devices move to the home setting in this "Gray Sheet" podcast.
For Asthmapolis, The Name Changes And The Focus Too
Digital health startup Asthmapolis has changed its name to Propeller Health, reflecting its broader focus to include chronic obstructive pulmonary disease.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.